1.
Silencing CACYBP suppresses lung adenocarcinoma growth via CDK1 inhibition. Biomol Biomed [Internet]. 2025 Mar. 19 [cited 2025 Aug. 22];25(8):1801–1815. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/11849